Esperion(ESPR) - 2023 Q2 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Alexis Callahan - Head of Investor Relations Sheldon Koenig - President and Chief Executive Officer Eric Warren - Chief Commercial Officer Benjamin Halladay - Chief Financial Officer JoAnne Foody - Chief Medical Officer Betty Swartz - Chief Strategy Officer Conference Call Participants Dennis Ding - Jefferies Serge Belanger - Needham & Company Joseph Thome - Cowen Thomas Shrader - BTIG J ...